Angiodynamics ANGO
NASDAQ ANGO
$12.02 +0.13 (+1.09%)
At close: Oct 22, 2026 · 4:00 PM EDT

Angiodynamics (ANGO) Cash from Discontinued Operations (2017 - 2019)

Updated

Angiodynamics (ANGO) recorded Cash from Discontinued Operations of -$5.41 million in fiscal Q3 2019 (quarter ended Feb 28, 2019), compared with -$4.12 million a year earlier.

Analysis

Angiodynamics (ANGO) Cash from Discontinued Operations (2017 - 2019) Analysis & Trends

On a TTM basis, Angiodynamics' Cash from Discontinued Operations came in at -$20.48 million as of Feb 28, 2019.

  • Quarterly Cash from Discontinued Operations has ranged from -$5.73 million in fiscal Q2 2019 to -$4.12 million in fiscal Q3 2018 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discont. Ops (Qtr)
1 Thermo Fisher Scientific 250.06 Bn 229.21 Bn 4.88 Bn -
2 Abbott Laboratories 177.62 Bn 148.71 Bn 7.27 Bn -
3 Danaher 161.58 Bn 145.40 Bn 3.61 Bn -
4 Intuitive Surgical 153.84 Bn 134.26 Bn 2.08 Bn -
5 Medtronic 123.63 Bn 89.50 Bn 6.34 Bn -
6 Stryker 117.79 Bn 103.90 Bn 4.50 Bn -
7 Boston Scientific 66.71 Bn 61.72 Bn 3.85 Bn -
8 Becton Dickinson 54.60 Bn 51.75 Bn 2.32 Bn 74.00 Mn
9 Edwards Lifesciences 51.95 Bn 36.07 Bn 1.35 Bn -
10 Angiodynamics 509.94 Mn 342.66 Mn 48.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Feb 28, 2019 -5.41 Mn
Nov 30, 2018 -5.73 Mn
Aug 31, 2018 -5.24 Mn
Feb 28, 2018 -4.12 Mn
Nov 30, 2017 -4.66 Mn
Aug 31, 2017 -4.97 Mn
API Access

Angiodynamics Cash from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-discontinued-operations&ticker=ANGO&period=max&api_key=YOUR_API_KEY